AI assistant
Sending…
SOLIGENIX, INC. — Director's Dealing 2022
Nov 21, 2022
35119_dirs_2022-11-21_c3518d46-ca77-4764-94b2-1358eebfe213.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2022-11-17
Reporting Person: Parks Diane L. (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-11-17 | Stock Option (Right to Buy) | $0.65 | A | 46154 | Acquired | 2032-11-16 | Common Stock (46154) | Direct |
Footnotes
F1: The stock option vests ratably on each of February 17, 2023, May 17, 2023, August 17, 2023 and November 17, 2023.
More from SOLIGENIX, INC.
Regulatory Filings
2026
May 28
Capital/Financing Update
2026
May 28
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Capital/Financing Update
2026
May 8
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3